| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (Cortex KO) / (Cortex WT) | Abundance Ratio (log2): (Cortex KO) / (Cortex WT) | Abundance Ratio P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Adj. P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Variability [%]: (Cortex KO) / (Cortex WT) | Abundances (Grouped): Cortex KO | Abundances (Grouped): Cortex WT | Abundances (Grouped) CV [%]: Cortex KO | Abundances (Grouped) CV [%]: Cortex WT | Abundances (Scaled): F1: 129, Sample, Cortex KO, 1 | Abundances (Scaled): F1: 130, Sample, Cortex KO, 2 | Abundances (Scaled): F1: 131, Sample, Cortex KO, 3 | Abundances (Scaled): F1: 126, Sample, Cortex WT, 1 | Abundances (Scaled): F1: 127, Sample, Cortex WT, 2 | Abundances (Scaled): F1: 128, Sample, Cortex WT, 3 | Abundances (Normalized): F1: 129, Sample, Cortex KO, 1 | Abundances (Normalized): F1: 130, Sample, Cortex KO, 2 | Abundances (Normalized): F1: 131, Sample, Cortex KO, 3 | Abundances (Normalized): F1: 126, Sample, Cortex WT, 1 | Abundances (Normalized): F1: 127, Sample, Cortex WT, 2 | Abundances (Normalized): F1: 128, Sample, Cortex WT, 3 | Abundance: F1: 129, Sample, Cortex KO, 1 | Abundance: F1: 130, Sample, Cortex KO, 2 | Abundance: F1: 131, Sample, Cortex KO, 3 | Abundance: F1: 126, Sample, Cortex WT, 1 | Abundance: F1: 127, Sample, Cortex WT, 2 | Abundance: F1: 128, Sample, Cortex WT, 3 | Abundances Count: F1: 129, Sample, Cortex KO, 1 | Abundances Count: F1: 130, Sample, Cortex KO, 2 | Abundances Count: F1: 131, Sample, Cortex KO, 3 | Abundances Count: F1: 126, Sample, Cortex WT, 1 | Abundances Count: F1: 127, Sample, Cortex WT, 2 | Abundances Count: F1: 128, Sample, Cortex WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medium | P42866 | Mu-type opioid receptor OS=Mus musculus OX=10090 GN=Oprm1 PE=1 SV=1 | 0.035 | 1.724 | 4 | 1 | 1 | 1 | 398 | 44.4 | 8.25 | 1.076 | 0.11 | 0.589125168 | 0.974756398 | 26.21 | 111.7 | 88.3 | 20.78 | 38.35 | 115.6 | 108 | 76.4 | 143.4 | 85.4 | 71.1 | 50.3 | 47 | 33.2 | 62.4 | 37.1 | 30.9 | 47.2 | 42.4 | 33.2 | 55.8 | 32.3 | 30.9 | 1 | 1 | 1 | 1 | 1 | 1 | cell communication;cellular homeostasis;defense response;metabolic process;regulation of biological process;response to stimulus;transport | cytoplasm;endosome;membrane | catalytic activity;protein binding;receptor activity;signal transducer activity;transporter activity | "Pf00001, Pf02076, Pf10323, Pf10328" | 18390 | Oprm1 | 10 | Peptide ligand-binding receptors; G-protein activation | ENSMUSG00000000766.18 | Morphine addiction; Neuroactive ligand-receptor interaction; Estrogen signaling pathway | "Non-odorant GPCRs; GPCRs, Class A Rhodopsin-like; Peptide GPCRs; GPCRs, Other" | 0 |